MedPath

Acute and Chronic inflammatory responses induced by smoking in individuals being susceptible and non-susceptible for development of COPD: from specific disease phenotyping towards novel therapy (study 2).

Completed
Conditions
emphysema
10046304
chronic obstructive bronchitis (COPD)
Registration Number
NL-OMON32401
Lead Sponsor
niversitair Medisch Centrum Groningen
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
300
Inclusion Criteria

*Age *18 and *75 years
*Age, pack years, FEV1/FVC and FEV1% predicted must fit in one of the 9 groups of table 4.1 (see protocol )
*Physically and mentally able to undergo the total study protocol
*Written informed consent

Exclusion Criteria

*Participation in another study
* Alpha-1-antitrypsin deficiency
* Selected grade 1-3 co-morbidity listed in the ACE-27 (areas marked red)
* Active pulmonary infection like tuberculosis, pneumonia, flue, tracheobronchitis
* Active extra-pulmonary infection like hepatitis A-C, cystitis, gastro-enteritis etc
*Pulmonary diseases like sarcoidosis, pulmonary fibrosis, silicosis, hypersensitivity pneumonitis, asthma
*Life threatening diseases like carcinoma, AIDS (including HIV+), acute leukaemia etc
*Medication that may affect the results of the study: NSAID*s, immunosuppressive agents like prednisolon, metotrexate, azathioprine

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath